Zymeworks Inc. Stock Toronto S.E.
Equities
ZYME
CA98985W1023
Biotechnology & Medical Research
Sales 2024 * | 95.49M 131M | Sales 2025 * | 107M 146M | Capitalization | 607M 830M |
---|---|---|---|---|---|
Net income 2024 * | -87M -119M | Net income 2025 * | -90M -123M | EV / Sales 2024 * | 5.56 x |
Net cash position 2024 * | 75.44M 103M | Net cash position 2025 * | 75.78M 104M | EV / Sales 2025 * | 4.96 x |
P/E ratio 2024 * |
-7.29
x | P/E ratio 2025 * |
-6.33
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.25% |
Latest transcript on Zymeworks Inc.
1st Jan change | Capi. | |
---|---|---|
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |